198 related articles for article (PubMed ID: 9058744)
1. Differences between graft-versus-leukemia and graft-versus-host reactivity. I. Interaction of donor immune T cells with tumor and/or host cells.
Rocha M; Umansky V; Lee KH; Hacker HJ; Benner A; Schirrmacher V
Blood; 1997 Mar; 89(6):2189-202. PubMed ID: 9058744
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
[TBL] [Abstract][Full Text] [Related]
3. Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice.
Müerköster S; Rocha M; Crocker PR; Schirrmacher V; Umansky V
Blood; 1999 Jun; 93(12):4375-86. PubMed ID: 10361136
[TBL] [Abstract][Full Text] [Related]
4. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
Müerköster S; Laman JD; Rocha M; Umansky V; Schirrmacher V
Clin Cancer Res; 2000 May; 6(5):1988-96. PubMed ID: 10815924
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
Schirrmacher V; Müerköster S; Umansky V
Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
[TBL] [Abstract][Full Text] [Related]
6. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.
Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y
Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333
[TBL] [Abstract][Full Text] [Related]
7. Changes in liver glycogen and lipid metabolism during transient graft-versus-host (GvH) and graft-versus-leukemia (GvL) reactivity.
Lee K; Hacker H; Umansky V; Schirrmacher V; Rocha M
Int J Oncol; 1996 Oct; 9(4):635-43. PubMed ID: 21541563
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
[TBL] [Abstract][Full Text] [Related]
9. Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice.
Gresser I; Greco G; Santini SM; Woodrow D; Mecchia M; Parlato S; Logozzi M; Venditti M; Maunoury MT; Belardelli F
J Interferon Cytokine Res; 1998 Sep; 18(9):667-79. PubMed ID: 9781805
[TBL] [Abstract][Full Text] [Related]
10. Effective immune rejection of advanced metastasized cancer.
Schirrmacher V; Beckhove P; Kruger A; Rocha M; Umansky V; Fichtner K; Hull W; Zangemeisterwittke U; Griesbach A; Jurianz K; Vonhoegen P
Int J Oncol; 1995 Mar; 6(3):505-21. PubMed ID: 21556565
[TBL] [Abstract][Full Text] [Related]
11. Transfer of long-lasting tumor immunity by immune T cells from MHC congenic mice: migration, survival and tumor-protectivity of cytotoxic donor cells.
Zangemeister-Wittke U; Schirrmacher V
Biotherapy; 1991; 3(4):319-29. PubMed ID: 1786195
[TBL] [Abstract][Full Text] [Related]
12. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
Truitt RL; Atasoylu AA
Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
[TBL] [Abstract][Full Text] [Related]
13. Acute graft-versus-host reaction in SCID mice leads to an abnormal expansion of CD8+ V beta 14+ and a broad inactivation of donor T cells followed by a host-restricted tolerance and a normalization of the TCR V beta repertoire in the chronic phase.
Schneider MK; Grönvik KO
Scand J Immunol; 1995 Apr; 41(4):373-83. PubMed ID: 7899825
[TBL] [Abstract][Full Text] [Related]
14. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells.
Sefrioui H; Billiau AD; Waer M
Transplantation; 2000 Jul; 70(2):348-53. PubMed ID: 10933162
[TBL] [Abstract][Full Text] [Related]
16. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.
Sykes M; Harty MW; Szot GL; Pearson DA
Blood; 1994 May; 83(9):2560-9. PubMed ID: 7909457
[TBL] [Abstract][Full Text] [Related]
18. During acute graft versus host disease CD28 deletion in donor CD8
Uri A; Lühder F; Kerkau T; Beyersdorf N
Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
[TBL] [Abstract][Full Text] [Related]
19. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
[TBL] [Abstract][Full Text] [Related]
20. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
